Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Palanivel Ganesan, Hyun-Myung Ko, In-Su Kim & Dong-Kug Choi. (2015) Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson’s disease models. International Journal of Nanomedicine 10, pages 6757-6772.
Read now
Read now
Shadab Md, Gulam Mustafa, Sanjula Baboota & Javed Ali. (2015) Nanoneurotherapeutics approach intended for direct nose to brain delivery. Drug Development and Industrial Pharmacy 41:12, pages 1922-1934.
Read now
Read now
Articles from other publishers (33)
Xu Zhang, Maohua Wang, Zhixian Liu, Ying Wang, Li Chen, Jiaqi Guo, Wentao Zhang, Yao Zhang, Chenjie Yu, Tongwu Bie, Youjun Yu & Bing Guan. (2023) Transnasal-brain delivery of nanomedicines for neurodegenerative diseases. Frontiers in Drug Delivery 3.
Crossref
Crossref
Peng Tang, Tianze Shen, Hairong Wang, Ruihan Zhang, Xingjie Zhang, Xiaoli Li & Weilie Xiao. (2023) Challenges and opportunities for improving the druggability of natural product: Why need drug delivery system?. Biomedicine & Pharmacotherapy 164, pages 114955.
Crossref
Crossref
Yingying Ding, Benson O. A. Botchway, Yong Zhang & Xuehong Liu. (2023) Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease. Food & Function 14:12, pages 5537-5550.
Crossref
Crossref
Shan Wen, Zhi-Ru Zou, Shuai Cheng, Hui Guo, Heng-Shuo Hu, Fan-Zhuo Zeng & Xi-Fan Mei. (2023) Ginsenoside Rb1 improves energy metabolism after spinal cord injury. Neural Regeneration Research 18:6, pages 1332.
Crossref
Crossref
Zhikun Shi, Hongyu Chen, Xu Zhou, Wei Yang & Yang Lin. (2022) Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease. Frontiers in Pharmacology 13.
Crossref
Crossref
K. Trideva Sastri, N. Vishal Gupta, Sharadha M, Souvik Chakraborty, Hitesh Kumar, Pallavi Chand, V. Balamuralidhara & D.V. Gowda. (2022) Nanocarrier facilitated drug delivery to the brain through intranasal route: A promising approach to transcend bio-obstacles and alleviate neurodegenerative conditions. Journal of Drug Delivery Science and Technology 75, pages 103656.
Crossref
Crossref
Jiao-jiao Wu, Yu Yang, Yan Wan, Jia Xia, Jin-Feng Xu, Li Zhang, Dong Liu, Lu Chen, Fei Tang, Hui Ao & Cheng Peng. (2022) New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease. Biomedicine & Pharmacotherapy 152, pages 113207.
Crossref
Crossref
P.K. Suresh. (2022) Saponins-uptake and Targeting Issues for Brain-specific Delivery for Enhanced
Cell Death Induction in Glioblastoma. Letters in Drug Design & Discovery 19:6, pages 473-480.
Crossref
Crossref
Seyede Nazanin Zarneshan, Sajad Fakhri & Haroon Khan. (2022) Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach. Pharmacological Research 177, pages 106099.
Crossref
Crossref
Ying‐Yuan Lu, Meng Fang, Zhi‐Yong Du, Jin‐Long Wang, Jin‐Yang Song, Yong Jiang, Xiao‐Yu Guo & Peng‐Fei Tu. (2021)
Comparative study on the main active components of
Baoyuan
decoction in plasma and urine of normal and heart failure rats
. Biomedical Chromatography 36:3.
Crossref
Crossref
Chhavi Bhalothia & Girima Nagda. (2022) Nanotherapeutics a promising approach for treatment of Parkinson’s disease. Materials Today: Proceedings 69, pages A1-A13.
Crossref
Crossref
Jyotsna Shankar, Geetha K.M & Barnabas Wilson. (2021) Potential applications of nanomedicine for treating Parkinson's disease. Journal of Drug Delivery Science and Technology 66, pages 102793.
Crossref
Crossref
Hong Wang, Yu Zheng, Qiang Sun, Zhen Zhang, Mengnan Zhao, Cheng Peng & Sanjun Shi. (2021) Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
De Jin, Yuqin Zhang, Yuehong Zhang, Liyun Duan, Rongrong Zhou, Yingyin Duan, Yuting Sun, Fengmei Lian & Xiaolin Tong. (2021) Panax Ginseng C.A.Mey. as Medicine: The Potential Use of Panax Ginseng C.A.Mey. as a Remedy for Kidney Protection from a Pharmacological Perspective. Frontiers in Pharmacology 12.
Crossref
Crossref
Weijie Xie, Xinyue Wang, Tianbao Xiao, Yibo Cao, Yumei Wu, Dongsheng Yang & Song Zhang. (2021) Protective Effects and Network Analysis of Ginsenoside Rb1 Against Cerebral Ischemia Injury: A Pharmacological Review. Frontiers in Pharmacology 12.
Crossref
Crossref
Ting Zhu, Lei Wang, Yicheng Feng, Guibo Sun & Xiaobo Sun. (2021) Classical Active Ingredients and Extracts of Chinese Herbal Medicines: Pharmacokinetics, Pharmacodynamics, and Molecular Mechanisms for Ischemic Stroke. Oxidative Medicine and Cellular Longevity 2021, pages 1-27.
Crossref
Crossref
Bang-Yue Luo, Jia-Li Jiang, Yi-Fan Fang, Fang Yang, Meng-Die Yin, Bing-Chen Zhang, Rui-Rui Zhao & Jing-Wei Shao. (2020) The effects of ginsenosides on platelet aggregation and vascular intima in the treatment of cardiovascular diseases: From molecular mechanisms to clinical applications. Pharmacological Research 159, pages 105031.
Crossref
Crossref
Xiaobing Li, Nan Mo & Zhenzhen Li. (2020) Ginsenosides: potential therapeutic source for fibrosis-associated human diseases. Journal of Ginseng Research 44:3, pages 386-398.
Crossref
Crossref
Young Hoon Kim, Yu Chul Kim, Dong-Jin Jang, Kyoung Ah Min, Jenisha Karmacharya, Thi-Thao-Linh Nguyen, Han-Joo Maeng & Kwan Hyung Cho. (2020) Development of 20(S)-Protopanaxadiol-Loaded SNEDDS Preconcentrate Using Comprehensive Phase Diagram for the Enhanced Dissolution and Oral Bioavailability. Pharmaceutics 12:4, pages 362.
Crossref
Crossref
Avinash P. Ingle, Sudhir Shende, Indarchand Gupta & Mahendra Rai. 2020. Biotechnological Production of Bioactive Compounds. Biotechnological Production of Bioactive Compounds
409
431
.
Meng Xu, Qing Ma, Chunlan Fan, Xue Chen, Huiming Zhang & Minke Tang. (2019) Ginsenosides Rb1 and Rg1 Protect Primary Cultured Astrocytes against Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury via Improving Mitochondrial Function. International Journal of Molecular Sciences 20:23, pages 6086.
Crossref
Crossref
Jiaqi Yan, Jialin Ren, Yu Zhu, Yanzhen Lin, Gang Chen, Dongzhi Hou, Zhufen Lv, Jiaxin Zhou, Yanzhong Chen & Fan Yang. (2019) Lymphatic clearance is the main drainage route of lamotrigine-loaded micelles following delivery to the brain. Journal of Pharmacy and Pharmacology 71:10, pages 1488-1496.
Crossref
Crossref
Mellar P. Davis & Bertrand Behm. (2019) Ginseng: A Qualitative Review of Benefits for Palliative Clinicians. American Journal of Hospice and Palliative Medicine® 36:7, pages 630-659.
Crossref
Crossref
Yumeng Shen, Xiang Cui, Shu Jiang, Da‐wei Qian & Jin‐ao Duan. (2019) Comparative pharmacokinetics of nine major bioactive components in normal and ulcerative colitis rats after oral administration of Lizhong decoction extracts by UPLC–TQ–MS/MS. Biomedical Chromatography 33:7, pages e4521.
Crossref
Crossref
Weijie Xie, Ping Zhou, Yifan Sun, Xiangbao Meng, Ziru Dai, Guibo Sun & Xiaobo Sun. (2018) Protective Effects and Target Network Analysis of Ginsenoside Rg1 in Cerebral Ischemia and Reperfusion Injury: A Comprehensive Overview of Experimental Studies. Cells 7:12, pages 270.
Crossref
Crossref
Md. Jakaria, Md. Ezazul Haque, Joonsoo Kim, Duk-Yeon Cho, In-Su Kim & Dong-Kug Choi. (2018) Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study. Oncotarget 9:71, pages 33601-33620.
Crossref
Crossref
Wenli Pan, Binli Xue, Chulei Yang, Linlin Miao, Lingli Zhou, Qiuyue Chen, Qing Cai, Yi Liu, Dongchun Liu, Haibing He, Yu Zhang, Tian Yin & Xing Tang. (2018) Biopharmaceutical characters and bioavailability improving strategies of ginsenosides. Fitoterapia 129, pages 272-282.
Crossref
Crossref
Hyeongmin Kim, Jong Hyuk Lee, Jee Eun Kim, Young Su Kim, Choong Ho Ryu, Hong Joo Lee, Hye Min Kim, Hyojin Jeon, Hyo-Joong Won, Ji-Yun Lee & Jaehwi Lee. (2018) Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability. Journal of Ginseng Research 42:3, pages 361-369.
Crossref
Crossref
Yu-Nan ZHAO, Xiao SHAO, Liu-Feng OUYANG, Lin CHEN & Ling GU. (2018) Qualitative detection of ginsenosides in brain tissues after oral administration of high-purity ginseng total saponins by using polyclonal antibody against ginsenosides. Chinese Journal of Natural Medicines 16:3, pages 175-183.
Crossref
Crossref
Tongkai Chen, Chuwen Li, Ye Li, Xiang Yi, Ruibing Wang, Simon Ming-Yuen Lee & Ying Zheng. (2017) Small-Sized mPEG–PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity. ACS Applied Materials & Interfaces 9:11, pages 9516-9527.
Crossref
Crossref
Tongkai Chen, Chuwen Li, Ye Li, Xiang Yi, Simon Ming-Yuen Lee & Ying Zheng. (2016) Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson’s Disease. Molecular Pharmaceutics 13:11, pages 3864-3875.
Crossref
Crossref
Touqeer Ahmed, Syed Hammad Raza, Afifa Maryam, William N. Setzer, Nady Braidy, Seyed Fazel Nabavi, Marcos Roberto de Oliveira & Seyed Mohammad Nabavi. (2016) Ginsenoside Rb1 as a neuroprotective agent: A review. Brain Research Bulletin 125, pages 30-43.
Crossref
Crossref
Chen Chen, Lisha Wang, Fangrui Cao, Xiaoqing Miao, Tongkai Chen, Qi Chang & Ying Zheng. (2016) Formulation of 20(S)-protopanaxadiol nanocrystals to improve oral bioavailability and brain delivery. International Journal of Pharmaceutics 497:1-2, pages 239-247.
Crossref
Crossref